Acquisition of Spyre and concurrent oversubscribed $210 million private investment positions the company to advance a leading inflammatory bowel disease (IBD) portfolio Spyre, the second spinout from Paragon Therapeutics, is advancing a pipeline of product candidates, led by SPY001 and SPY002, that are potentially best-in-class antibodies targeting a4b7 and TL1A, respectively, and which are expected … Read more
MADISON, Conn., June 22, 2023 /PRNewswire/ — Precision X-Ray, Inc. (“Precision”), a pioneer in cabinet X-ray irradiators, proudly announces the launch of our latest technology into Sterile Insect Technique (SIT). This game-changing solution provides unparalleled environmental control within our family of irradiators and champions the cause of non-GMO and environmentally friendly insect control methods. Our cutting-edge … Read more
SAN FRANCISCO, June 22, 2023 /PRNewswire/ — The global population health management market size is expected to reach USD 280.8 billion by 2030, expanding at a CAGR of 21.94% over the forecast period, according to a new report by Grand View Research, Inc. The healthcare industry is shifting toward the adoption of healthcare IT solutions, … Read more
SAN FRANCISCO, June 22, 2023 /PRNewswire/ — The global operating room equipment market size is expected to reach USD 75.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2023 to 2030. The key factors driving the market growth … Read more
MARLBOROUGH, Mass., June 21, 2023 /PRNewswire/ — AssayQuant® Technologies, Inc. introduces KinSight™ Kinome Profiling Services providing superior results including kinetic insights into selectivity and mechanisms of action for drug discovery. Kinase inhibitors are effective in targeting deregulation mechanisms that drive disease progression, yet only 15% of kinases have FDA-approved inhibitors. AssayQuant’s kinome profiling platform provides … Read more
BRANFORD, Conn., June 21, 2023 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today announced the closing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of … Read more
SAN DIEGO, June 21, 2023 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on June 20, 2023, the Human Capital Management Committee of Avidity’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 23,650 … Read more
NEW YORK, June 21, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee and the Board of Directors, as a material inducement … Read more
NORWOOD, Mass., June 21, 2023 /PRNewswire/ — Tekscan is proud to introduce F-Scan™ GO, the newest product in our award-winning line of gait analysis systems for the biomechanics community. The F-Scan GO allows your subject to enjoy full freedom of movement while you capture their natural in-shoe gait with the highest resolution data in the … Read more
MIAMI, June 21, 2023 /PRNewswire/ — PreCheck Health Services, a renowned provider of advanced medical diagnostics, is excited to announce its strategic partnership with a distinguished Dominican Republic medical entity, SD Wellness Center. This collaboration marks a significant milestone for PreCheck Health Services as it expands its operations into the vibrant healthcare market of the … Read more